Prospectus • Nov 28, 2024
Prospectus
Open in ViewerOpens in native device viewer

(incorporated under the laws of England and Wales) ________________________________________________________________
Series 1136, Series 1139, Series 1141, Series 1144, Series 1149, Series 1151, Series 1155, Series 1158, Series 1160, Series 1166, Series 1170, Series 1172, Series 1174, Series 1176, Series 1178, Series 1180, Series 1182, Series 1184, Series 1186, Series 1188
________________________________________________________________
This document (the "Prospectus") relates to each of the above-referenced Series of securities (as described in more detail in "The N&C Securities" below, the "N&C Securities") previously issued by Santander UK plc ("Santander UK") under its Notes and Certificates Programme (the "Programme").
The issuer of the N&C Securities is Santander UK plc (the "Issuer"). The payment of any amount due under the N&C Securities is subject to the Issuer's financial position and its ability to meet its obligations. This Prospectus, including the information incorporated by reference into this Prospectus (see "Information Incorporated by Reference" below), contains information describing the Issuer's business activities as well as certain financial information and material risks faced by the Issuer.
The N&C Securities are in the form of Notes issued by the Issuer under the Programme. The terms and conditions of the N&C Securities comprise (i) the Terms and Conditions in respect of each Tranche and Series of N&C Securities (the "General Conditions") as incorporated in relevant part by reference in this Prospectus from the 2017 Base Prospectus, 2018 Base Prospectus, 2019 Base Prospectus or 2020 Base Prospectus, as applicable (each as defined below - see "Information Incorporated by Reference"), as supplemented and completed by (ii) the Final Terms in respect of each Tranche and Series of the relevant N&C Securities (each, the "Final Terms"), as incorporated in relevant part by reference in this Prospectus (see "Information Incorporated by Reference"). The return on each Series of N&C Securities is dependent on the performance of the FTSE 100 Index (referred to in this Prospectus as the "Asset").
The Prospectus incorporates by reference certain information from the 2017 Base Prospectus, 2018 Base Prospectus, 2019 Base Prospectus, 2020 Base Prospectus, 2024 Base Prospectus and from the Final Terms of each Tranche and Series of the N&C Securities (see "Information Incorporated by Reference"). You should read this document together with such information incorporated by reference. Documents will be made available at the registered office of the Issuer and at https://www.santander.co.uk/aboutsantander/investor-relations/santander-uk-notes-certificates-programme.
Prospective investors should consider carefully the risks set forth in this document under "Risk Factors" below prior to making an investment decision with respect to the N&C Securities. If prospective investors are in any doubt about the risks or suitability of the N&C Securities, they should seek professional advice.
This Prospectus has been approved by the Financial Conduct Authority (the "FCA") as competent authority under Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA") (the "UK Prospectus Regulation") for the purposes of application by the Issuer to the FCA for each Series of the N&C Securities to be admitted to the official list of the FCA (the "Official List") and to the London Stock Exchange plc (the "London Stock Exchange") for each Series of N&C Securities to be admitted to trading on the London Stock Exchange's Main Market. The FCA only approves this Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the UK Prospectus Regulation. Such approval should not be considered as an endorsement of the Issuer or of the quality of the N&C Securities that are the subject of this Prospectus. Investors should make their own assessment as to the suitability of investing in the N&C Securities.
Application has been made to the FCA for each Series of the N&C Securities to be admitted to the official list of the FCA (the "Official List") and to the London Stock Exchange plc (the "London Stock Exchange") for each Series of the N&C Securities to be admitted to trading on the London Stock Exchange's Main Market.
References in this Prospectus to N&C Securities being "listed" (and all related references) shall mean that such N&C Securities have been admitted to trading on the London Stock Exchange's Main Market and have been admitted to the Official List. The London Stock Exchange's Main Market is a UK regulated market for the purposes of Regulation (EU) No 600/2014 on markets in financial instruments as it forms part of domestic law by virtue of the EUWA ("UK MiFIR").
The Issuer accepts responsibility for the information contained in this Prospectus. To the best of the knowledge of the Issuer, the information contained in this Prospectus is in accordance with the facts and this Prospectus makes no omission likely to affect its import.
The Final Terms in respect of each Tranche and Series of N&C Securies (as incorporated by reference in part herein) specifies the nature of the responsibility taken by the Issuer for the information relating to the Asset to which the N&C Securities relate and which is contained in such Final Terms.
Neither this Prospectus nor any other information supplied in connection with the Programme or any N&C Securities (i) is intended to provide the basis of any credit or other evaluation or (ii) should be considered as a recommendation by Santander UK (in its capacity as Issuer and Dealer) that any recipient of this Prospectus or any other information supplied in connection with the Programme or any N&C Securities should purchase any N&C Securities. Each investor contemplating purchasing any N&C Securities should make its own independent investigation of the financial condition and affairs, and its own appraisal of the creditworthiness, of the Issuer. Neither this Prospectus nor any other information supplied in connection with the Programme or the issue of any N&C Securities constitutes an offer or invitation by or on behalf of the Santander UK (in its capacity as Issuer and Dealer) to any person to subscribe for or to purchase any N&C Securities. Furthermore, neither this Prospectus, nor any other information supplied in connection with the Programme or any N&C Securities is, nor does it purport to be, investment advice. Unless expressly agreed otherwise with a particular investor, Santander UK (in its capacity as Issuer and Dealer) is not acting as an investment adviser or providing advice of any other nature, nor assumes any fiduciary obligation, to any investor in N&C Securities.
Neither the delivery of this Prospectus nor the offering, sale or delivery of any N&C Securities shall in any circumstances imply that the information contained herein concerning the Issuer is correct at any time subsequent to the date hereof or that any other information supplied in connection with the Programme is correct as of any time subsequent to the date indicated in the document containing the same. The Dealer expressly does not undertake to review the financial condition or affairs of the Issuer during the life of the Programme or to advise any investor in the N&C Securities of any information coming to their attention. Investors should review, inter alia, the most recently published documents incorporated by reference in this Prospectus (including any documents incorporated by reference pursuant to any supplements hereto) when deciding whether or not to purchase any N&C Securities.
The N&C Securities are not rated.
As at the date of this Prospectus, the long-term obligations of Santander UK are rated A by S&P, A1 by Moody's and A+ by Fitch, and the short-term obligations of Santander UK are rated A-1 by S&P, P-1 by Moody's and F1 by Fitch.
Each of S&P Global Ratings UK Limited ("S&P"), Moody's Investors Service Ltd ("Moody's") and Fitch Ratings Ltd ("Fitch") are established in the United Kingdom and are registered under Regulation (EC) No. 1060/2009 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK CRA Regulation").
S&P is not established in the European Union and has not applied for registration under Regulation (EC) No. 1060/2009 (as amended) (the "CRA Regulation"). The Issuer rating issued by S&P has been endorsed by S&P Global Ratings Europe Limited in accordance with the CRA Regulation. S&P Global Ratings Europe Limited is established in the European Union and registered under the CRA Regulation.
Moody's is not established in the European Union and has not applied for registration under the CRA Regulation. The Issuer rating issued by Moody's has been endorsed by Moody's Deutschland GmbH in accordance with the CRA Regulation. Moody's Deutschland GmbH is established in the European Union and registered under the CRA Regulation.
Fitch is not established in the European Union and has not applied for registration under the CRA Regulation. The Issuer rating issued by Fitch has been endorsed by Fitch Ratings Ireland Limited in accordance with the CRA Regulation. Fitch Ratings Ireland Limited is established in the European Union and registered under the CRA Regulation.
A security rating is not a recommendation to buy, sell or hold securities and may be subject to suspension, reduction or withdrawal at any time by the assigning rating agency.
Persons into whose possession offering material comes must inform themselves about and observe any such restrictions. This Prospectus does not constitute, and may not be used for or in connection with, an offer to any person to whom it is unlawful to make such an offer or a solicitation by anyone not authorised so to act.
The N&C Securities in bearer form for U.S. federal income tax purposes are subject to U.S. tax law requirements and may not be offered, sold or delivered within the United States or its possessions or to or for the account or benefit of U.S. Persons, except in certain transactions permitted by U.S. Treasury regulations. Terms used in this paragraph have the meanings given to them by the U.S. Internal Revenue Code of 1986 (the "Code") and the U.S. Treasury regulations promulgated thereunder.
The N&C Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or under any state securities laws and N&C Securities are subject to certain United States tax law requirements.
The N&C Securities, or interests therein, may not at any time be offered, sold, resold, traded, pledged, redeemed, transferred or delivered, directly or indirectly, in the United States (including any state of the United States and the District of Columbia), its territories, possessions and other areas subject to its jurisdiction (the "United States") or directly or indirectly offered, sold, resold, traded, pledged, redeemed, transferred or delivered to, or for the account or benefit of, any person who is (i) a "U.S. person" as defined in Regulation S under the Securities Act ("Regulation S"), (ii) a person who comes within any definition of U.S. person for the purposes of the United States Commodity Exchange Act of 1936, as amended (the "CEA") (including but not limited to a "U.S. person" as defined in the Interpretive Guidance and Policy Statement Regarding Compliance with Certain Swap Regulations promulgated by the Commodity Futures Trading Commission (the "CFTC") pursuant to the CEA and a person other than a "Non-United States person" as defined in CFTC Rule 4.7(a)(1)(iv) excluding for the purposes of CFTC Rule 4.7(a)(1)(iv)(D) the exception for qualified eligible persons who are not "Non-United States persons"), or (iii) a "United States person" as defined in the U.S. Internal Revenue Code of 1986 and the U.S. Treasury regulations promulgated thereunder, in each case, as such definition may be amended, modified or supplemented from time to time (each such person, a "U.S. Person").
The N&C Securities do not constitute and have not been marketed as, contracts of sale of a commodity for future delivery (or options thereon) subject to the CEA, and trading in the N&C Securities has not been approved by the CFTC pursuant to the CEA.
This Prospectus does not constitute an offer to sell or the solicitation of an offer to buy any N&C Securities in any jurisdiction to any person to whom it is unlawful to make the offer or solicitation in such jurisdiction. The distribution of this Prospectus and the offer or sale of N&C Securities may be restricted by law in certain jurisdictions. Santander UK (in its capacity as Issuer and Dealer) does not represent that this Prospectus may be lawfully distributed, or that any N&C Securities may be lawfully offered, in compliance with any applicable registration or other requirements in any such jurisdiction, or pursuant to an exemption available thereunder, or assume any responsibility for facilitating any such distribution or offering, or that all actions have been taken by Santander UK (in its capacity as Issuer and Dealer) which would permit a public offering of any N&C Securities or distribution of this Prospectus in any jurisdiction where action for that purpose is required. In particular, no action has been taken by Santander UK (in its capacity as Issuer and Dealer) which would permit a public offering of any N&C Securities or distribution of this Prospectus in any jurisdiction where action for that purpose is required. Accordingly, no N&C Securities may be offered or sold, directly or indirectly, and neither this Prospectus nor any advertisement or other offering material may be distributed or published in any jurisdiction, except under circumstances that will result in compliance with any applicable laws and regulations.
Persons into whose possession this Prospectus or any N&C Securities may come must inform themselves about, and observe any such restrictions on the distribution of this Prospectus and the offering and sale of N&C Securities.
Each potential investor in the N&C Securities must determine the suitability of that investment in light of its own circumstances. In particular, each potential investor may wish to consider, either on its own or with the help of its financial and other professional advisers, whether it:
An investment in N&C Securities may entail significant risks not associated with investments in conventional securities such as debt or equity securities.
In making an investment decision, investors must rely on their own examination of the Issuer and the terms of the N&C Securities being offered, including the merits and risks involved.
The Dealer and its affiliates have engaged and may in the future engage in investment banking and/or commercial banking transactions with, and may perform services for the Issuer and its respective affiliates.
The Dealer does not make any representation to any investor in the N&C Securities regarding the legality of its investment under any applicable laws. Any investor in the N&C Securities should satisfy itself that it is able to bear the economic risk of an investment in the N&C Securities for an indefinite period of time.
Purchasers of such N&C Securities are deemed to have sufficient knowledge, experience and professional advice to make their own investment decisions and to have undertaken their own legal, financial, tax, accounting and other business evaluation of the risks and merits of investments in such N&C Securities and should ensure that they fully understand the risks associated with investments of this nature which are intended to be sold only to sophisticated investors. Purchasers of N&C Securities are solely responsible for making their own independent appraisal of an investigation into the business, financial condition, prospects, creditworthiness, status and affairs of the Asset and the information relating to the Asset and the level or fluctuation of the Asset.
IMPORTANT – EEA RETAIL INVESTORS – The N&C Securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ("EEA"). For these purposes, a "retail investor" means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II"); or (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the "Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended, the "EU Prospectus Regulation"). Consequently, no key information document is required by Regulation (EU) No 1286/2014 (as amended, the "EU PRIIPs Regulation") for offering or selling the N&C Securities or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the N&C Securities or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.
Amounts payable under the N&C Securities are calculated by reference to the FTSE 100 Index, which is provided by FTSE International Limited. As at the date of this Prospectus, FTSE International Limited appears in the register of administrators and benchmarks established and maintained by the Financial Conduct Authority pursuant to Article 36 of Regulation (EU) No. 2016/1011 as it forms part of domestic law by virtue of the EUWA (as amended, the "UK Benchmarks Regulation"). The registration status of any administrator under the UK Benchmarks Regulation is a matter of public record and, save where required by applicable law, the Issuer does not intend to update this Prospectus to reflect any change in the registration status of the administrator.
Amounts payable under the N&C Securities are calculated by reference to the FTSE 100 Index, which is provided by FTSE International Limited. As at the date of this Prospectus, FTSE International Limited does not appear in the register of administrators and benchmarks established and maintained by the European Securities and Markets Authority ("ESMA") (the "ESMA Register") pursuant to Article 36 of Regulation (EU) No. 2016/1011 (as amended, the "EU Benchmarks Regulation"). The registration status of any administrator under the EU Benchmarks Regulation is a matter of public record and, save where required by applicable law, the Issuer does not intend to update this Prospectus to reflect any change in the registration status of the administrator. As far as the Issuer is aware, the FTSE 100 Index does not fall within the scope of the EU Benchmarks Regulation.
In this document, references to:
The consolidated annual financial statements of Santander UK for the years ended 31 December 2022 and 31 December 2023 were prepared in accordance with the International Financial Reporting Standards ("IFRS").
In this Prospectus, all references to billions are references to one thousand millions. Due to rounding, the numbers presented throughout this Prospectus may not add up precisely, and percentages may not precisely reflect absolute figures.
All references in this document to "GBP", "Sterling" and "£" are to the currency of the United Kingdom.
In this Prospectus, unless the contrary intention appears, a reference to a law or a provision of a law is a reference to that law or provisions as extended, amended or re-enacted
Other than in relation to the documents which are deemed to be incorporated by reference (see "Documents Incorporated by Reference"), the information on the websites to which this Prospectus refers does not form part of this Prospectus and has not been scrutinised or approved by the FCA.
Unless otherwise specified, all calculations and determinations in respect of the N&C Securities shall be made by Santander UK (acting in such capacity, the "Calculation Agent").
| SUMMARY OF THE N&C SECURITIES | 8 |
|---|---|
| RISK FACTORS | 15 |
| INFORMATION INCORPORATED BY REFERENCE | 16 |
| THE N&C SECURITIES | 23 |
| GENERAL INFORMATION | 26 |
This Summary should be read as an introduction to the Prospectus. Any decision to invest in the N&C Securities should be based on consideration of the Prospectus as a whole by the investor. In certain circumstances, the investor could lose all or part of the invested capital. Where a claim relating to the information contained in the Prospectus is brought before a court, the plaintiff investor might, under the national law, have to bear the costs of translating the Prospectus before the legal proceedings are initiated. No civil liability shall attach to any responsible person solely on the basis of this Summary, including any translation thereof, unless it is misleading, inaccurate or inconsistent when read together with the other parts of the Prospectus or it does not provide, when read together with the other parts of the Prospectus, key information in order to aid investors when considering whether to invest in the N&C Securities.
You are about to purchase a product that is not simple and may be difficult to understand.
(each a "N&C Security", and, together, the "N&C Securities").
The Issuer is Santander UK plc ("Santander UK" or the "Issuer"). Its registered office is at 2 Triton Square, Regent's Place, London, NW1 3AN and its Legal Entity Identifier (LEI) is: PTCQB104N23FMNK2RZ28.
The Authorised Offeror is Santander UK plc with its address at 2 Triton Square, Regent's Place, London, NW1 3AN (the "Distributor") and its Legal Entity Identifier (LEI) is PTCQB104N23FMNK2RZ28.
The Prospectus was approved on 26 November 2024 by the Financial Conduct Authority (the "FCA") of 12 Endeavour Square, London E20 1JN, United Kingdom (Telephone number: +44 (0)20 7066 1000; Website: https//www.fca.org.uk).
The Issuer is a public limited liability company incorporated and domiciled in England and Wales. The Issuer is registered on the Companies House under company number 02294747. The Issuer's LEI is PTCQB104N23FMNK2RZ28.
Summary
Santander UK's principal activity is financial services, mainly in the UK. The business is managed and reported on the basis of the following segments, which are strategic business units that offer different products and services, have different customers and require different technology and marketing strategies.
Retail & Business Banking: consists of two business units, Homes and Everyday Banking. Homes provides prime UK mortgage lending to owner occupiers and buy-to-let landlords with small portfolios. Everyday Banking provides banking services and unsecured lending to individuals and small businesses as well alongside wealth management for high-net-worth clients.
Consumer Finance: provides prime auto consumer financing for invidivuals, businesses, and automotive distribution networks.
Corporate & Commercial Banking: provides banking products and service sto SMEs, mid-sized and larger corporates, typically with annual turnovers of between £2m and £500m as well as to Local Authorities and Housing Associations.
Corporate Centre: provides treasury services for asset and liability management of Santander UK's balance sheet.
Santander UK is a wholly owned subsidiary of Santander UK Group Holdings Limited, which is a subsidiary of Banco Santander, S.A.. Banco Santander, S.A. and its subsidiary Santusa Holding, S.L together hold the entire issued share capital of Santander UK Group Holdings Limited (the "Santander Group").
The current managing directors of the Issuer are as follows:
• Dave Gledill
• José María Roldán • Pamela Walkden
PricewaterhouseCoopers LLP ("PWC") are the independent auditors of Santander UK plc and have audited the historical financial information of Santander UK plc for the financial years ended 31 December 2023 and 31 December 2022.
| As at (audited, save where indicated) | ||
|---|---|---|
| 31 December 2023 £ |
31 December 2022 £ |
|
| Total assets | 275,448m | 285,213m |
| Senior unsecured – public benchmark1 | 12.7bn | 14.3bn |
| Senior unsecured – privately placed1 | 0.8bn | 0.6bn |
| Subordinated liabilities and other equity instruments1 | 4.2bn | 3.9bn |
| Loans and advances to customers | 207,435m | 219,716m |
| Deposits by customers | 190,850m | 195,568m |
| Total equity | 14,623m | 14,407m |
| Stage 3 ratio2 | 1.51% | 1.26% |
| Common Equity Tier 1 capital (CET1) ratio or other relevant prudential capital adequacy ratio depending on issuance (unaudited) |
15.4 % | 15.4% |
| Total capital ratio (unaudited) | 21.5% | 20.4% |
Excludes any foreign exchange and hedge accounting
Stage3 ratio = (Stage3 drawn + Stage3 undrawn assets)/(total drawn assets + Stage3 undrawn assets)
Summarised consolidated balance sheet of the Issuer (extracted from the Issuer's unaudited Half-Yearly Financial Statement for the six months ended 30 June 2024):
| As at (unaudited) | ||
|---|---|---|
| 30 June 2024 | 31 December 2023 | |
| £bn | £bn | |
| Total assets | 264.2 | 275.4 |
|---|---|---|
| Total customer deposits | 184.8 | 190.9 |
| Total liabilities | 250.2 | 260.8 |
| Total liabilities and equity | 264.2 | 275.5 |
| Total Qualifying Regulatory Capital | 14.3 | 14.6 |
| Risk Weighted Assets | 67.1 | 67.8 |
| Total Capital Ratio | 21.3% | 21.5% |
| Liquidity Coverage Ratio | 140% | 157% |
| Consolidated income statement (extracted from the Issuer's Annual Report for the year ended 31 December 2023): | ||
|---|---|---|
| 31 December 2023 | 31 December 2022 | |
| £m | £m | |
| Interest and similar income | 11,617 | 6,708 |
| Interest expense and similar charges | (6,959) | (2,283) |
| Net interest income | 4,658 | 4,425 |
| Fee and commission income | 804 | 839 |
| Fee and commission expense | (501) | (509) |
| Net fee and commission income | 303 | 330 |
| Other operating income | 135 | 201 |
| Total operating income | 5,096 | 4,956 |
| Operating expenses before credit impairment (charges) provisions and charges | (2,456) | (2,343) |
| Credit impairment (charges)/write-backs | (205) | (320) |
| Provisions for other liabilities and charges | (335) | (419) |
| Total operating credit impairment (charges), provisions and charges | (540) | (739) |
| Profit from continuing operations before tax | 2,100 | 1,874 |
| Tax on profit from continuing operations | (559) | (480) |
| Profit from continuing operations after tax | 1,541 | 1,394 |
| Profit from discontinued operations after tax | - | - |
| Profit after tax | 1,541 | 1,394 |
| Attributable to: | ||
| Equity holders of the parent | 1,541 | 1,394 |
| Non-controlling interests | - | - |
| Profit after tax | 1,541 | 1,394 |
Summarised consolidated income statement of the Issuer (extracted from the Issuer's unaudited Half-Yearly Financial Statement for the six months ended 30 June 2024):
| 30 June 2024 | 30 June 2023 | |
|---|---|---|
| £m | £m | |
| Net interest income | 2,104 | 2,361 |
| Non-interest income | 191 | 233 |
| Total operating income | 2,295 | 2,594 |
| Operating expenses before credit impairment charges, provisions and charges | (1,279) | (1,219) |
| Credit impairment write backs / (losses) | (61) | (105) |
| Provisions for other liabilities and charges | (142) | (148) |
| Total operating credit impairment losses, provisions and charges | (203) | (253) |
| Profit before tax | 813 | 1,122 |
| Tax on profit from continuing operations | (213) | (308) |
| Profit after tax | 600 | 814 |
Qualifications in audit report on historical financial information
There are no qualifications in the audit report of the Issuer on its historical financial information.
What are the key risks that are specific to the Issuer?
The Issuer is subject to the following key risks:
What are the main features of the N&C Securities?
Type and class of N&C Securities being offered and/or admitted to trading, including security identification numbers
Each N&C Security are Equity Index Linked Notes which are uniquely identified by a Series Number, Tranche Number, ISIN, and Common Code (as specified in the table below).
Each N&C Security were delivered by the Issuer free of payment on their respective Issue Date (as specified in the table below) at 100 per cent. of the Aggregate Nominal Amount (the "Issue Price").
The N&C Securities are cleared through Euroclear and Clearstream, Luxembourg.-
| Series | Tranche | ISIN | Common Code | Issue Date | Maturity Date |
|---|---|---|---|---|---|
| 1136 | 1 | XS1866007542 | 186600754 | 3 September 2018 | 30 December 2024 |
| 1139 | 1 | XS1894675914 | 189467591 | 2 November 2018 | 25 February 2025 |
| 1139 | 2 | XS1894675914 | 189467591 | 18 January 2019 | 25 February 2025 |
| 1141 | 1 | XS1917956440 | 191795644 | 11 January 2019 | 23 April 2025 |
| 1144 | 1 | XS1939334675 | 1939334674 | 15 February 2019 | 10 June 2025 |
| 1149 | 1 | XS1970465974 | 197046597 | 15 April 2019 | 12 August 2025 |
| 1151 | 1 | XS2005531103 | 200553110 | 28 June 2019 | 7 October 2025 |
| 1155 | 1 | XS2035095459 | 203509545 | 1 August 2019 | 9 December 2025 |
| 1158 | 1 | XS2063664275 | 206366427 | 1 November 2019 | 20 January 2026 |
| 1160 | 1 | XS2085849870 | 208584987 | 9 December 2019 | 16 March 2026 |
| 1166 | 1 | XS2101558992 | 2101558992 | 3 February 2020 | 11 May 2026 |
| 1170 | 1 | XS2133252218 | 213325221 | 1 April 2020 | 6 July 2026 |
| 1172 | 1 | XS2159802359 | 215980235 | 1 June 2020 | 31 July 2026 |
| 1174 | 1 | XS2186175571 | 218617557 | 10 June 2020 | 1 September 2026 |
| 1176 | 1 | XS2196322585 | 219632258 | 3 July 2020 | 2 November 2026 |
| 1178 | 1 | XS2222052719 | 222205271 | 28 August 2020 | 21 December 2026 |
| 1180 | 1 | XS2238784826 | 223878482 | 2 October 2020 | 15 February 2027 |
| 1182 | 1 | XS2262949378 | 226294937 | 14 January 2021 | 15 March 2027 |
| 1184 | 1 | XS2294359141 | 229435914 | 11 February 2021 | 1 June 2027 |
| 1186 | 1 | XS2326318990 | 232631899 | 29 April 2021 | 13 July 2027 |
| 1188 | 1 | XS2352402544 | 235240254 | 18 June 2021 | 24 August 2027 |
The currency of the N&C Securities is Pound Sterling ("£" or "GBP"). The specified denominations of each N&C Security are £1,000 and integral multiples of £1.00 in excess thereof up to and including £1,999. No N&C Securities in definitive form will be issued with a denomination exceeding £1,999.
Each N&C Security will be redeemed on their respective Maturity Date (as specified in the table above).
The N&C Securities will give each investor the right to receive a return (subject to any prior purchase and cancellation or early redemption) on the Maturity Date of the applicable N&C Securities, together with certain ancillary rights such as the right to receive notice of certain determinations and events.
The return under the applicable N&C Securities payable at the end of the term of the applicable N&C Securities on the Maturity Date of such N&C Securities will be determined by reference to the performance of the Reference Item as follows:
No interest shall be payable on the N&C Securities.
The "Reference Item" will be the FTSE 100 Index (Bloomberg Screen UKX
| Series | Initial Valuation Date | Averaging Dates | Cash Amount 1 | Cash Amount 2 |
|---|---|---|---|---|
| 1136 | 28 December 2018 | 24 June 2024 to 23 December 2024 | £1.26 | £1.025 |
| 1139 | 25 February 2019 | 19 August 2024 to 18 February 2025 | £1.32 | £1.025 |
| 1141 | 23 April 2019 | 14 October 2024 to 14 April 2025 | £1.30 | £1.025 |
| 1144 | 10 June 2019 | 3 December 2024 to 3 June 2025 | £1.32 | £1.025 |
| 1149 | 12 August 2019 | 5 February 2025 to 5 August 2025 | £1.30 | £1.025 |
| 1151 | 7 October 2019 | 31 March 2025 to 30 September 2025 | £1.28 | £1.025 |
| 1155 | 9 December 2019 | 2 June 2025 to 2 December 2025 | £1.24 | £1.025 |
| 1158 | 20 January 2020 | 14 July 2025 to 13 January 2026 | £1.22 | £1.025 |
| 1160 | 16 March 2020 | 9 September 2025 to 9 March 2026 | £1.24 | £1.025 |
| 1166 | 11 May 2020 | 5 November 2025 to 5 May 2026 | £1.24 | £1.025 |
| 1170 | 6 July 2020 | 29 December 2025 to 29 June 2026 | £1.21 | £1.025 |
| 1172 | 3 August 2020 | 26 January 2026 to 24 July 2026 | £1.13 | £1.025 |
| 1174 | 1 September 2020 | 27 February 2026 to 27 August 2026 | £1.12 | £1.025 |
| 1176 | 2 November 2020 | 27 April 2026 to 26 October 2026 | £1.09 | £1.025 |
| 1178 | 21 December 2020 | 15 June 2026 to 14 December 2026 | £1.07 | £1.005 |
| 1180 | 15 February 2021 | 10 August 2026 to 8 February 2027 | £1.07 | £1.005 |
| 1182 | 15 March 2021 | 8 September 2026 to 8 March 2027 | £1.08 | £1.005 |
| 1184 | 1 June 2021 | 25 November 2026 to 25 May 2027 | £1.09 | £1.005 |
| 1186 | 13 July 2021 | 6 January 2027 to 6 July 2027 | £1.16 | £1.005 |
| 1188 | 24 August 2021 | 18 February 2027 to 17 August 2027 | £1.15 | £1.005 |
The N&C Securities are governed by English law and the rights thereunder will be construed accordingly.
The N&C Securities constitute direct, unconditional, unsecured and unsubordinated obligations of the Issuer and rank pari passu without preference amongst themselves and, subject to any applicable statutory provisions or judicial order, at least equally with all other present and future direct, unconditional, unsecured and unsubordinated obligations of the Issuer.
Description of restrictions on free transferability of the N&C Securities
Selling restrictions apply to offers, sales or transfers of the N&C Securities under the applicable laws in various jurisdictions. A purchaser of the N&C Securities is required to make certain agreements and representations as a condition to purchasing the N&C Securities.
Subject to the above, the N&C Securities are freely transferable.
Application for N&C Securities has been made for listing on the Official List of the Financial Conduct Authority and for admission to trading on the Main Market of the London Stock Exchange.
The N&C Securities are subject to the following key risks:
The N&C Securities are not being publicly offered.
There are no estimated expenses charged to an investor by the Issuer.
See the item entitled "The Authorised Offeror(s)" above.
The Issuer is the entity requesting the admission to trading of the N&C Securities.
The N&C Securities are not being publicly offered at this time. The net proceeds from the original issue of the N&C Securities will be applied by the Issuer for its general corporate purposes.
The offers of the N&C Securities were not subject to an underwriting agreement on a firm commitment basis.
Save for any fees payable to the Dealer and any Authorised Offeror, so far as the Issuer is aware, no person involved in the issue of the N&C Securities had an interest material to the offer.
In addition to being the Issuer, Santander UK acts in a number of capacities in relation to the N&C Securities (e.g. Calculation Agent and Dealer). Santander UK shall have only the duties and responsibilities expressly agreed to by it in its relevant capacity and shall not, by virtue of its acting in any other capacity, be deemed to have other duties or responsibilities or be deemed to hold a standard of care other than as expressly provided with respect to each such capacity.
In the ordinary course of its business Santander UK (or an affiliate) may effect transactions for its own account and may enter into hedging transactions with respect to the N&C Securities or the Reference Item, which may affect the market price, liquidity or value of the N&C Securities and Santander UK (or an affiliate) may have confidential information in relation to the Reference Item or any derivative instruments referencing them, but which Santander UK (or an affiliate) is under no obligation (and may be subject to legal prohibition) to disclose.
Prospective investors should note that the risks relating to the Issuer, its industry and the N&C Securities summarised in the Summary are the risks that the Issuer believes to be the most essential to an assessment by a prospective investor of whether to consider an investment in such N&C Securities. However, as the risks which the Issuer faces relate to events and depend on circumstances that may or may not occur in the future, prospective investors should consider not only the information on the key risks summarised in the Summary but also, among other things, the risks and uncertainties described below.
An investment in the N&C Securities may involve a high degree of risk. In purchasing N&C Securities, investors assume the risk that the Issuer may become insolvent or otherwise be unable to make all payments due in respect of the N&C Securities. There are a wide range of factors which individually or together could result in the Issuer becoming unable to make all payments due in respect of the N&C Securities. The Issuer may not be aware of all relevant factors and certain factors which it currently deems not to be material may become material as a result of the occurrence of events outside the Issuer's control. The Issuer has identified in this Prospectus a number of factors which could materially adversely affect its business and ability to make payments due under the N&C Securities.
In addition, factors which are material for the purpose of assessing the market risk associated with the N&C Securities are detailed below. The factors discussed below regarding the risks of acquiring or holding any N&C Securities are not exhaustive, and additional risks and uncertainties that are not presently known to the Issuer or that the Issuer currently believes to be immaterial could also have a material impact on the N&C Securities.
Prospective investors should also read the detailed information set out elsewhere in this Prospectus and reach their own views prior to making any investment decision.
Investors should consider the 'Risk Factors' set out on pages 1 to 58 of the 2024 Base Prospectus and which are incorporated by reference herein (see "Information Incorporated by Reference "below).
The information set out under paragraph 2 (Information incorporated by reference) below contained in the documents set out under paragraph 1 (Source documents) below have been previously published and shall be incorporated into, and form part of, this Prospectus (save as provided below):
(k) the Final Terms in respect of an issue of £20,000,000 Equity Index Linked Notes due 2027 (ISIN: XS2352402544) ("Series 1188") (available at: https://www.santander.co.uk/assets/s3fs-public/documents/issue\_1188\_signed.pdf);
(each document in this sub-section 1.3 a "Final Terms").
Any documents and information incorporated by reference in the above documents does not form part of this Prospectus.
The information specified in the table below is incorporated into this Prospectus by reference. Any non-incorporated parts of a document specified in paragraph 1 (Source documents) above which are not listed in the cross-reference lists below are not incorporated by reference in this Prospectus and are deemed not relevant for an investor or are otherwise covered elsewhere in this Prospectus.
Whole document
| Audit report | Pages 108 to 116 |
|---|---|
| Consolidated financial statements | Pages 117 to 124 |
| Notes to the financial statements | Pages 125 to 194 |
Whole document
| From the 2022 Annual Report | |
|---|---|
| Audit report | Pages 120 to 128 |
| Consolidated financial statements | Pages 129 to 136 |
| Notes to the financial statements | Pages 137 to 208 |
Whole document
| References to Santander entities | Page viii |
|---|---|
| Risk Factors | Pages 1 to 57 |
| Description of the Issuer | Pages 58 to 64 |
| General Description of the Programme | Pages 66 to 71 |
| How the Return on N&C Securities is Calculated (section I.A. only (Final redemption amount (with barrier condition)) |
Pages 72 to 75 |
| Commonly Asked Questions (excluding questions 2 to 6, 29 and 30) | Pages 88 to 100 |
| Form of the N&C Securities | Pages 216 to 221 |
| Book-Entry Clearance Systems and Settlement | Pages 223 to 226 |
| Taxation | Pages 227 to 230 |
| Important Notice to Purchasers and Transferees of N&C Securities | Page 231 |
| Subscription and Sale | Pages 232 to 236 |
| General Information | Pages 237 to 244 |
| From the 2020 Base Prospectus | |
| General Terms and Conditions of the N&C Securities (excluding the Inflation Index Annex) |
Pages 59 to 134 |
| Form of Final Terms for Non Exempt N&C Securities | Pages 135 to 167 |
| From the 2019 Base Prospectus | |
| General Terms and Conditions of the N&C Securities (excluding the Inflation Index Annex) |
Pages 57 to 133 |
| Form of Final Terms for Non Exempt N&C Securities | Pages 134 to 166 |
| From the 2018 Base Prospectus | |
| General Terms and Conditions of the N&C Securities (excluding the Inflation Index Annex) |
Pages 108 to 184 |
| Form of Final Terms for Non Exempt N&C Securities | Pages 185 to 215 |
| From the 2017 Base Prospectus | |
| General Terms and Conditions of the Securities (excluding the Inflation Index Annex) |
Pages 97 to 164 |
| Form of Final Terms for Non Exempt Securities | Pages 165 to 293 |
| From Series 1188 |
| Part A – Contractual Terms | Pages 1 to 8 |
|---|---|
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to | Pages 9 to 15 |
| Trading)) |
| From Series 1186 | |
|---|---|
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1184 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1182 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1180 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1178 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1176 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1174 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1172 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1170 |
Part A – Contractual Terms Pages 1 to 8
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
|---|---|
| From Series 1166 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1160 | |
| Part A – Contractual Terms | Pages 1 to 9 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 10 to 16 |
| From Series 1158 | |
| Part A – Contractual Terms | Pages 1 to 9 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 10 to 16 |
| From Series 1155 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1151 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1149 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1144 | |
| Part A – Contractual Terms | Pages 1 to 8 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 9 to 15 |
| From Series 1141 | |
| Part A – Contractual Terms | Pages 1 to 7 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 8 to 14 |
| From Trance One of Series 1139 | |
|---|---|
| Part A – Contractual Terms | Pages 1 to 7 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 8 to 14 |
| From Tranche Two of Series 1139 | |
| Part A – Contractual Terms | Pages 1 to 7 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 8 to 14 |
| From Series 1136 | |
| Part A – Contractual Terms | Pages 1 to 7 |
| Part B – Other Information (excluding paragraph 1 (Listing and Admission to Trading)) |
Pages 8 to 14 |
Any statement contained herein or in a document which is deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purpose of this Prospectus to the extent that a subsequent statement which is deemed to be incorporated by reference herein or contained herein modifies or supersedes such earlier statement (whether expressly, by implication or otherwise), provided, however, that such statement shall only form part of the Prospectus to the extent that it is contained in a document, all or the relevant portion of which is incorporated by reference by way of a supplement produced in accordance with Article 23 of the UK Prospectus Regulation. Any statement so modified or superseded shall not, except as so modified or superseded, constitute part of this Prospectus.
The securities which are the subject of this Prospectus are each of the Series of securities previously issued by Santander UK plc under its Notes and Certificate Programme as set out in the following table (together, the "N&C Securities"):
| Series | Aggregate Principal Amount |
Issue Date | Maturity Date | ISIN | Common Code |
|---|---|---|---|---|---|
| 1136 | £8,930,112 | 3 September 2018 | 30 December 2024 | XS1866007542 | 186600754 |
| 1139 | £22,107,629 | Trance One: 2 November 2018 Tranche Two: 18 January 2019 |
25 February 2025 | XS1894675914 | 189467591 |
| 1141 | £4,623,772 | 11 January 2019 | 23 April 2025 | XS1917956440 | 191795644 |
| 1144 | £18,940,809 | 15 February 2019 | 10 June 2025 | XS1939334675 | 1939334674 |
| 1149 | £7,525,095 | 15 April 2019 | 12 August 2025 | XS1970465974 | 197046597 |
| 1151 | £6,907,632 | 28 June 2019 | 7 October 2025 | XS2005531103 | 200553110 |
| 1155 | £4,472,715 | 1 August 2019 | 9 December 2025 | XS2035095459 | 203509545 |
| 1158 | £7,027,790 | 1 November 2019 | 20 January 2026 | XS2063664275 | 206366427 |
| 1160 | £4,511,380 | 9 December 2019 | 16 March 2026 | XS2085849870 | 208584987 |
| 1166 | £4,177,216 | 3 February 2020 | 11 May 2026 | XS2101558992 | 2101558992 |
| 1170 | £3,856,994 | 1 April 2020 | 6 July 2026 | XS2133252218 | 213325221 |
| 1172 | £4,635,447 | 1 June 2020 | 31 July 2026 | XS2159802359 | 215980235 |
| 1174 | £1,175,285 | 10 June 2020 | 1 September 2026 | XS2186175571 | 218617557 |
| 1176 | £13,225,540 | 3 July 2020 | 2 November 2026 | XS2196322585 | 219632258 |
| 1178 | £15,636,746 | 28 August 2020 | 21 December 2026 | XS2222052719 | 222205271 |
| 1180 | £39,381,201 | 2 October 2020 | 15 February 2027 | XS2238784826 | 223878482 |
| 1182 | £1,558,439 | 14 January 2021 | 15 March 2027 | XS2262949378 | 226294937 |
| 1184 | £2,834,541 | 11 February 2021 | 1 June 2027 | XS2294359141 | 229435914 |
| 1186 | £2,247,346 | 29 April 2021 | 13 July 2027 | XS2326318990 | 232631899 |
| 1188 | £1,901,665 | 18 June 2021 | 24 August 2027 | XS2352402544 | 235240254 |
The terms and conditions of each series of N&C Securities comprise:
• the Terms and Conditions of the relevant Series of N&C Securities (the "General Conditions") as incorporated in relevant part by reference in this Prospectus from the 2020 Base Prospectus, 2019 Base Prospectus, 2018 Base Prospectus or 2017 Base Prospectus (as applicable) (see both "Applicable General Conditions" below and "Information Incorporated by Reference" above); and
• as supplemented by the Final Terms of the relevant Tranche Series of N&C Securities (the "Final Terms") as incorporated in relevant part by reference in this Prospectus (see "Information Incorporated by Reference" above).
The table below sets out which of the 2020 Base Prospectus, 2019 Base Prospectus, 2018 Base Prospectus or 2017 Base Prospectus provide the applicable General Conditions of the relevant Series of N&C Securities.
| Series | Applicable Base Prospectus |
|---|---|
| 1136 | 2017 Base Prospectus |
| 1139 | 2017 Base Prospectus |
| 1141 | 2018 Base Prospectus |
| 1144 | 2018 Base Prospectus |
| 1149 | 2018 Base Prospectus |
| 1151 | 2018 Base Prospectus |
| 1155 | 2018 Base Prospectus |
| 1158 | 2019 Base Prospectus |
| 1160 | 2019 Base Prospectus |
| 1166 | 2019 Base Prospectus |
| 1170 | 2019 Base Prospectus |
| 1172 | 2019 Base Prospectus |
| 1174 | 2019 Base Prospectus |
| 1176 | 2019 Base Prospectus |
| 1178 | 2019 Base Prospectus |
| 1180 | 2019 Base Prospectus |
| 1182 | 2020 Base Prospectus |
| 1184 | 2020 Base Prospectus |
| 1186 | 2020 Base Prospectus |
| 1188 | 2020 Base Prospectus |
Application will be made by the Issuer for the N&C Securities to be admitted to the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange.
Each Tranche and Series of N&C Securies was previously listed and admitted to trading on Euronext Dublin. Pursuant to a delisting announcement dated on or about the date on which the N&C Securities are admitted to the Official List of the Financial Conduct Authortiy and to trading on the Main Market of the London Stock Exchange, each Tranche and Series of N&C Securities will be delisted from Euronext Dublin.
For as long as this Prospectus remains in effect or any N&C Securities remain outstanding, copies of the following documents will, when published, be available for inspection at https://www.santander.co.uk/about-santander/investor-relations or, in the case of the documents listed at (a) below, on the website of Companies House athttps://beta.companieshouse.gov.uk/ and in the case of the documents listed at (f) below, in physical form, during usual business hours on any weekday (Saturdays and public holidays excepted) at the registered office of the Issuer and at the specified offices of the Paying Agents:
The N&C Securities in bearer and registered form have been accepted for clearance through Euroclear and Clearstream, Luxembourg. The appropriate Common Code and ISIN for each Tranche of bearer N&C Securities allocated by Euroclear and Clearstream, Luxembourg is specified in the applicable Final Terms.
The address of Euroclear is 1 Boulevard du Roi Albert II, B.1210 Brussels, Belgium and the address of Clearstream, Luxembourg is 42 Avenue J. F. Kennedy, L-1855 Luxembourg.
Save as disclosed below, there has been no significant change in the financial position or financial performance of the Santander UK Group (including Santander UK) since 30 June 2024 (being the end of the last financial period for which interim financial information has been published) and there has been no material adverse change in the prospects of Santander UK plc since 31 December 2023 (being the date of its last published audited consolidated annual financial statements).
Following the FCA's Motor Market review in 2019 which resulted in a change in rules in January 2021, Santander Consumer (UK) plc (SCUK) has received a number of county court claims and complaints in respect of its historical use of discretionary commission arrangements (DCAs) prior to the 2021 rule changes. In January 2024, the FCA commenced a review of the use of DCAs between lenders and credit brokers (the FCA review) and paused the handling of these complaints originally until September 2024. The FCA announced in July 2024 that it expected to share the outcome of its Review by May 2025 and that the pause in respect of handling of these complaints was extended to 4 December 2025. A claim has also been issued against SCUK, Santander UK plc and others in the Competition Appeal Tribunal (CAT), alleging that SCUK's historical DCAs in respect of used car financing operated in breach of the Competition Act 1998. This is currently paused until the end of July 2025 connected to the outcome of the FCA Review.
The outcome of the FCA's Review may be informed by the judgment of the Court of Appeal handed down on 25 October 2024 in relation to cases against other lenders involving DCAs (noting that the lenders subject to the Court of Appeal's judgment have indicated they intend to seek permission to appeal), and the outcome of a judicial review of a final decision by the Financial Ombudsman Service (FOS) against another lender that was heard in October 2024.
In light of the Court of Appeal judgment, the Santander UK Group has recognised a provision of £295m in its financial results for the quarter ended 30 September 2024. This includes estimates for operational and legal costs (including litigation costs) and potential awards, based on various scenarios using a range of assumptions (such as the outcome of any Supreme Court appeal, the scope and timeframe of any redress scheme, applicable time periods, claims rates and compensatory interest rates). The outcome of the FCA's Review and/or adverse outcomes from litigation could result in material costs. These matters mean that there are currently significant uncertainties as to the extent of any misconduct, if any, as well as the perimeter of commission models, nature, extent and timing of any remediation action if required. As such, the ultimate financial impact could be materially higher or lower than the amount provided and it is not practicable to quantify the extent of any remaining contingent liability.
There are no governmental, legal or arbitration proceedings (including any such proceedings which are pending or threatened of which the Issuer is aware) which may have or had, in the 12 months prior to the date hereof, a significant effect on the financial position or profitability of the Santander UK Group or Santander UK plc and its subsidiaries.
Save as set out in the applicable Final Terms, the Issuer does not intend to provide any post-issuance information in relation to any issue of N&C Securities.
The net proceeds from each issue of N&C Securities have been applied by the Issuer for its general corporate purposes.
2 Triton Square Regent's Place London NW1 3AN United Kingdom
Santander UK plc 2 Triton Square Regent's Place London NW1 3AN United Kingdom
Citibank, N.A., London Branch Citigroup Centre Canada Square Canary Wharf London E14 5LB United Kingdom
Citibank Europe plc 1 North Wall Quay Dublin 1 Ireland
Citibank Europe plc 1 North Wall Quay Dublin 1 Ireland
Citibank, N.A., London Branch Citigroup Centre Canada Square Canary Wharf London E14 5LB United Kingdom
To the Dealer as to English law Ashurst LLP London Fruit & Wool Exchange 1 Duval Square London E1 6PW United Kingdom
To the Issuer PricewaterhouseCoopers LLP 1 Embankment Place London WC2N 6RH United Kingdom
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.